AA Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.62M Buy
4,686
+39
+0.8% +$39.8K 0.68% 46
2026
Q1
$4.27M Buy
4,647
+100
+2% +$101K 0.6% 48
2025
Q4
$4.89M Buy
4,547
+495
+12% +$473K 0.9% 35
2025
Q3
$3.09M Buy
4,052
+625
+18% +$465K 0.61% 42
2025
Q2
$2.67M Sell
3,427
-1,243
-27% -$966K 0.58% 41
2025
Q1
$3.86M Buy
4,670
+199
+4% +$166K 0.94% 33
2024
Q4
$3.45M Sell
4,471
-136
-3% -$113K 0.92% 36
2024
Q3
$4.08M Buy
4,607
+318
+7% +$286K 1.18% 29
2024
Q2
$3.88M Sell
4,289
-224
-5% -$179K 1.37% 26
2024
Q1
$3.51M Buy
4,513
+3,879
+612% +$2.76M 1.42% 22
2023
Q4
$370K Buy
+634
New +$370K 0.25% 44

Other funds holding LLY

AA Financial Advisors's LLY Position: Q2 2026 in Review

AA Financial Advisors increased its Eli Lilly (LLY) stake by 0.84% in Q2 2026, buying an estimated $39.8K and bringing the position to 4,686 shares worth $5.62M. The position accounts for 0.68% of the portfolio, ranked #46.

AA Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AA Financial Advisors held 4,686 shares of Eli Lilly worth $5.62M as of Q2 2026.
  • AA Financial Advisors bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.68% of AA Financial Advisors's portfolio in Q2 2026, its #46 holding.
  • AA Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AA Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.